Global AR Lab & Response Network Collaborations

Global AR Lab & Response Network Collaborations - Collaborations will happen in more than 38 countries, including: Argentina, Australia, Bangladesh, Botswana, Brazil, Burkina Faso, Cambodia, Chile, China, Costa Rica, Ecuador, Egypt, Ethiopia, Greece, Guatemala, Hong Kong, India, Indonesia, Iraq, Israel, Japan, Jordan, Kenya, Korea, Lebanon, Libya, Malaysia, Mexico, Morocco, New Zealand, Pakistan, Palestine, Philippines, South Africa, Sudan, Taiwan, Thailand, Togo, and Vietnam.

In 2021, more than 19 partners have implemented collaborations in more than 38 countries to launch the Global AR Lab & Response Network, tackling threats like:

CDC's Global AR Lab & Response Network Map

Countries Where Global AR Lab & Response Network Partners are Working

Collaborations are happening in more than 38 countries, including: Argentina, Australia, Bangladesh, Botswana, Brazil, Burkina Faso, Cambodia, Chile, China, Costa Rica, Ecuador, Egypt, Ethiopia, Greece, Guatemala, Hong Kong, India, Indonesia, Iraq, Japan, Jordan, Kenya, Korea, Lebanon, Libya, Malaysia, Mexico, Morocco, New Zealand, Pakistan, Palestine, Philippines, South Africa, Sudan, Taiwan, Thailand, Togo, and Vietnam.

Antimicrobial Resistance in Health Care

The Antibiotic Resistance in Communities and Healthcare (ARCH) projects aim to better understand the burden, molecular epidemiology, and drivers of resistant bacteria in humans in multiple low- and middle-income countries by tracking colonization (carrying and potentially spreading harmful pathogens without infection) in communities and healthcare settings. Researchers are using whole genome sequencing to explore isolate relatedness, transmission (spread) dynamics, and patterns of resistance across the community-hospital environments. The data from the studies will improve our understanding of the source of new resistance threats, how prevalent or widespread the threat is, and how we can tailor prevention strategies to mitigate the impact. Additional collaborative work is happening through CDC’s Global Action in Healthcare Network to address emerging threats in healthcare settings through rapid detection and response.

icddr,b
Bangladesh
icddr,b is the principal investigator for the project in Bangladesh working to carry out study activities in Dhaka. This work is also supported by the CDC-Bangladesh Country Office.

Universidad del Desarrollo (UDD)
Chile
UDD is the principal investigator for the project in Chile, carrying out study activities in four sites across the country. This work is also supported by the CDC-South America Regional Office.

University of Pennsylvania
Botswana
The University of Pennsylvania is the principal investigator for the ARCH project in Botswana. They work with the University of Botswana to carry out project activities in three districts across the country: Gaborone, Mochudi, and Molepole. This work is also supported by the CDC-Botswana Country Office.


Washington State University (WSU)
Kenya and Guatemala
WSU is the principal investigator for projects in Kenya and Guatemala. In Kenya, the team works with the University of Nairobi to carry out ARCH activities in urban (Nairobi) and rural (Siaya) sites. This work is also supported by the CDC-Kenya Country Office. In Guatemala, the WSU team works with Universidad del Valle de Guatemala to carry out activities in Quetzaltenango, a city in the western highlands. This work is also supported by the CDC-Central America Regional Office.

Drug-resistant Gonorrhea

World Health Organization (WHO)
Strengthening global and national surveillance systems of Neisseria gonorrhoeae through the Enhanced Gonococcal Antimicrobial Surveillance Programme (eGASP) in Thailand, Philippines, Cambodia, and South Africa
WHO will expand the Enhanced Gonococcal Antimicrobial Surveillance Programme (eGASP), a CDC and WHO initiative monitoring trends in antimicrobial susceptibility of Neisseria gonorrhoeae. Gonorrhea is a sexually transmitted disease that can spread easily and has progressively developed resistance to the antibiotics used to treat it. Data from eGASP sites will strengthen understanding of how drug-resistant gonorrhea spreads in geographically diverse areas and inform national and international clinical treatment guidelines.

Drug-resistant Fungi

FIOTEC
Strengthening a national surveillance system for antimicrobial-resistant Candida in Brazil
FIOTEC aims to expand the Brazilian Antimicrobial Resistance Surveillance System (BR-GLASS) to improve monitoring of antimicrobial-resistant Candida species in Brazil. This work will expand and enhance infection prevention and control strategies, improving patient outcomes and protecting the healthcare workforce. 

Northwestern University
Surveillance of antimicrobial-resistant Candida auris in a Pakistan healthcare system
Northwestern University will build local capacity to detect, track, and report antimicrobial-resistant Candida auris and other antimicrobial-resistant Candida species at Aga Khan University Hospital in Pakistan with an emphasis on a description of molecular mechanisms of antimicrobial resistance. This work will inform the response when threats are detected and put into place the mechanisms for molecular detection of outbreaks.

Pakistan National Institute of Health
Monitoring and preventing antimicrobial-resistant Candida auris in Pakistan
The Pakistan National Institute of Health will improve the capacity to detect, monitor, and control emerging antimicrobial-resistant Candida auris in Pakistan healthcare settings. This work will enhance infection prevention and control strategies, improving patient outcomes, and protecting the healthcare workforce.

University of Nairobi
Monitoring and preventing antimicrobial-resistant Candida auris in Kenya (MAP-AMR Kenya)
The University of Nairobi will improve the capacity to detect, monitor, and control emerging antimicrobial-resistant Candida auris in Kenya’s healthcare settings. This work will enhance infection prevention and control strategies, improving patient outcomes and protecting the healthcare workforce.

Resistant Enteric (intestinal) Pathogens (germs)

American University of Beirut
Establishment of MENA regional whole genome sequencing laboratory for reference and research on enteric (gut) pathogens in PulseNet Middle East
There is limited information in the Middle East and North Africa region on the occurrence and severity of typhoid cases, outbreaks, and associated antimicrobial susceptibility patterns. In the U.S., there are an estimated 4,100 drug-resistant cases each year. Most people in the U.S. become infected while traveling to countries where typhoid is common. Researchers will collect samples for 10 months from nine countries (Iraq, Jordan, Palestine, Libya, Morocco, Egypt, Sudan, Pakistan, and Lebanon) to sequence and analyze. After collection, researchers will host training sessions for participating countries to establish surveillance platforms and demonstrate the quality and quantity of data generated from a surveillance program. The data will also be uploaded to the National Center for Biotechnology Information website and available to the public. The information collected will help the scientific community understand the spread of the various typhoid sequence types in these countries.

Association of Public Health Laboratories (APHL)
Improving detection of enteric (gut) pathogens including those that are resistant to antimicrobials in PulseNet International by expanding data collection in Southeast Asia
There is limited information in the Asia Pacific region on the occurrence and severity of enteric disease outbreaks and associated antimicrobial susceptibility patterns. APHL will work across Australia, Bangladesh, China, Hong Kong, India, Japan, Korea, Malaysia, New Zealand, Philippines, Taiwan, Thailand, Vietnam to increase enteric disease data and facilitate data sharing between countries. The information collected will help the scientific community understand the spread of enteric bacterial disease and antimicrobial resistance in these countries.

Family Health International (FHI360)
Improving water, sanitation, and hygiene and environmental monitoring in Kenya to address drug-resistant enteric pathogen transmission
Water, sanitation and hygiene (WASH) systems are critical to human health, survival, and development, yet poorly functioning systems may be spreading antimicrobial-resistant enteric pathogens and their genes. In countries challenged in providing adequate sanitation for their entire populations, the role of the environment may be significant in contributing to exposure to antimicrobial-resistant enteric pathogens. In Kenya, Family Health International will work with local laboratories to improve environmental monitoring of antimicrobial-resistant enteric pathogens—for example in water and wastewater systems—and work to assess risk factors for exposure to those pathogens to understand and improve prevention measures.

Resistant Respiratory Pathogens

American Society for Microbiology (ASM)
Enhancing global laboratory capacity in Mexico and Brazil to detect, assess, and respond to emerging antimicrobial resistance in Bordetella pertussis
ASM will work with partners to strengthen laboratory system data reporting and improve antimicrobial resistance detection and response for Bordetella pertussis. A vaccine-preventable disease, Bordetella pertussis,  was recently added to CDC’s antimicrobial-resistant Watch List as a potential growing threat. ASM plans to work with partners in Mexico and Brazil to identify emerging resistance in this pathogen and help respond when and where outbreaks occur.

Global Scientific Solutions for Health
Improving detection and response to antimicrobial-resistant Meningococcal disease in Burkina Faso and Togo
Global Scientific Solutions for Health (GGS) will reinforce surveillance systems for antimicrobial-resistant Neisseria meningitidis in Burkina Faso and Togo and create tailored work plans for each. The data and findings from this project will guide public health decision making and planning for how to track and respond to the threat of meningitis outbreaks in partner countries and the broader region. 

Koperasi Jasa Institut Riset Eijkman
Improving capacity to detect and monitor emerging antimicrobial resistance in bacterial respiratory pathogens, with a focus on Streptococcus pneumoniae, in Indonesia
Koperasi Jasa Institut Riset Eijkman will build on existing work with CDC and enhance capacity of clinical laboratories at select secondary or tertiary hospitals in Indonesia for identification and characterization of antimicrobial-resistant respiratory germs, with a focus on Streptococcus pneumoniae. This research will also create guidelines and opportunities for other regional facilities to replicate the laboratories’ success.